Literature DB >> 18397551

The polymicrobial hypothesis of bacterial vaginosis causation: a reassessment.

W E Josey1, J R Schwebke.   

Abstract

The cause of bacterial vaginosis remains controversial. The two leading hypotheses are that Gardnerella vaginalis is the specific aetiologic agent versus the polymicrobial hypothesis that G. vaginalis acts in concert with other bacteria, principally anaerobes, to produce the disease. Here we reassess the prevailing polymicrobial hypothesis, finding it conceptually problematical. No host initiating factors as postulated have been identified, nor is there conclusive evidence that G. vaginalis lacks diagnostic specificity for the disease. The polymicrobial hypothesis, presupposing a unique disruption of vaginal microecology, is inconsistent with the epidemiological profile of the syndrome, which is that of a sexually transmitted disease. The epidemiological and clinical similarities between bacterial vaginosis and trichomoniasis suggest a similar pathogenetic process; i.e., primary causation by a specific agent, with secondary anaerobic activation and resultant amine production.

Entities:  

Mesh:

Year:  2008        PMID: 18397551     DOI: 10.1258/ijsa.2007.007260

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  16 in total

1.  DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo.

Authors:  Saul R Hymes; Tara M Randis; Thomas Yang Sun; Adam J Ratner
Journal:  J Infect Dis       Date:  2013-02-19       Impact factor: 5.226

2.  Tinidazole vs metronidazole for the treatment of bacterial vaginosis.

Authors:  Jane R Schwebke; Renee A Desmond
Journal:  Am J Obstet Gynecol       Date:  2010-12-17       Impact factor: 8.661

3.  Effect of sexual activity on vaginal colonization with hydrogen peroxide-producing lactobacilli and Gardnerella vaginalis.

Authors:  Caroline Mitchell; Lisa E Manhart; Katherine K Thomas; Kathy Agnew; Jeanne M Marrazzo
Journal:  Sex Transm Dis       Date:  2011-12       Impact factor: 2.830

4.  Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis.

Authors:  Sujit D Rathod; Karl Krupp; Jeffrey D Klausner; Anjali Arun; Arthur L Reingold; Purnima Madhivanan
Journal:  Sex Transm Dis       Date:  2011-09       Impact factor: 2.830

Review 5.  The aetiology of bacterial vaginosis.

Authors:  Y Turovskiy; K Sutyak Noll; M L Chikindas
Journal:  J Appl Microbiol       Date:  2011-03-14       Impact factor: 3.772

6.  Race of male sex partners and occurrence of bacterial vaginosis.

Authors:  Mark A Klebanoff; William W Andrews; Jun Zhang; Rebecca M Brotman; Tonja R Nansel; Kai-Fun Yu; Jane R Schwebke
Journal:  Sex Transm Dis       Date:  2010-03       Impact factor: 2.830

7.  Higher vaginal pH in Trichomonas vaginalis infection with intermediate Nugent score in reproductive-age women-a hospital-based cross-sectional study in Odisha, India.

Authors:  Padmalaya Das; Tapoja Swain; Jyoti Ranjan Mohanty; Shalini Sinha; Bijay Padhi; Belen Torondel; Oliver Cumming; Bijaya Panda; Arati Nayak; Pinaki Panigrahi
Journal:  Parasitol Res       Date:  2018-06-23       Impact factor: 2.289

8.  Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns.

Authors:  Raina N Fichorova; Andrew B Onderdonk; Hidemi Yamamoto; Mary L Delaney; Andrea M DuBois; Elizabeth Allred; Alan Leviton
Journal:  mBio       Date:  2011-01-18       Impact factor: 7.867

9.  Association between semen exposure and incident bacterial vaginosis.

Authors:  Maria F Gallo; Lee Warner; Caroline C King; Jack D Sobel; Robert S Klein; Susan Cu-Uvin; Anne M Rompalo; Denise J Jamieson
Journal:  Infect Dis Obstet Gynecol       Date:  2011-12-08

10.  Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women.

Authors:  Katherine Fethers; Jimmy Twin; Christopher K Fairley; Freya J I Fowkes; Suzanne M Garland; Glenda Fehler; Anna M Morton; Jane S Hocking; Sepehr N Tabrizi; Catriona S Bradshaw
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.